TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...
In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H.
Zacks Small Cap Research on MSN12d
IMNN: Gearing Up to Initiate Phase 3 Ovarian Cancer Trial in 1Q25…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...
John Innes Centre researchers and partners used a model plasmid called RK2 that is used globally to study clinically relevant plasmids that transmit antimicrobial resistance. Their initial focus was a ...
John Innes Centre researchers and partners used a model plasmid called RK2 that is used globally to study clinically relevant plasmids that transmit antimicrobial resistance. Their initial focus was a ...
As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is tapping contracting juggernaut Thermo Fisher Scientific to help meet its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback